Strategic partnerships to reduce risk in drug development
In order to decrease overall risk in the drug discovery and development process, the decision base needs to be improved. Solutions that can provide better data for decision-making before starting clinical trials are critical.
A better basis for decision- Eliminate projects that will fail due to unverified target biology
- Minimize late failures caused by conclusions from misleading data
Sidec’s solutions provide unique opportunities, by showing whether the clinically relevant molecular complex is formed correctly, in the right location, in cells and tissue. This novel and exclusive information, that will improve your basis for decision, is available through our
Research Partnership
